Literature DB >> 17540905

Pharmacological treatment of the overweight patient.

George A Bray1, Frank L Greenway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17540905     DOI： 10.1124/pr.59.2.2

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  42 in total

Review 1.  Gustatory and reward brain circuits in the control of food intake.

Authors:  A J Oliveira-Maia; C D Roberts; S A Simon; M A L Nicolelis
Journal:  Adv Tech Stand Neurosurg       Date:  2011

Review 2.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

Review 3.  New central targets for the treatment of obesity.

Authors:  Bruce J Sargent; Nicholas A Moore
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

Review 4.  The bone-adipose axis in obesity and weight loss.

Authors:  J Gómez-Ambrosi; A Rodríguez; V Catalán; G Frühbeck
Journal:  Obes Surg       Date:  2008-06-19       Impact factor: 4.129

5.  Further delineation between typical and atypical dopamine uptake inhibitors: effects on food-maintained behavior and food consumption.

Authors:  Jonathan M Slezak; Rajeev I Desai; Jonathan L Katz
Journal:  Behav Pharmacol       Date:  2017-02       Impact factor: 2.293

6.  Obesity-programmed mice are rescued by early genetic intervention.

Authors:  Viviana F Bumaschny; Miho Yamashita; Rodrigo Casas-Cordero; Verónica Otero-Corchón; Flávio S J de Souza; Marcelo Rubinstein; Malcolm J Low
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

Review 7.  Obesity in bipolar disorder: an overview.

Authors:  Susan L McElroy; Paul E Keck
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

Review 8.  Lifestyle and pharmacological approaches to weight loss: efficacy and safety.

Authors:  George A Bray
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

Review 9.  Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.

Authors:  Konstantinos Tziomalos; Hariklia V Dimitroula; Niki Katsiki; Christos Savopoulos; Apostolos I Hatzitolios
Journal:  Mediators Inflamm       Date:  2010-03-07       Impact factor: 4.711

Review 10.  The use of lorcaserin in the management of obesity: a critical appraisal.

Authors:  Bo Bai; Yu Wang
Journal:  Drug Des Devel Ther       Date:  2010-12-20       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.